SESSION VI – Other plasma cell dyscrasias
Chair: Elena Zamagni (Bologna)
11:30-11:35 Introduction Elena Zamagni (Bologna)
11:35-11:55 Interactive case: Josephine Vos (Amsterdam)
How I treat Waldenstrom's macroglobulinemia
11:55-11:15 Case-based lecture: How I treat amyloidosis Giampaolo Merlini (Pavia)
11:15-12:35 Case-based lecture: Stefan Knop (Würzburg)
Is this myeloma kidney? A case of significantly elevated free
serum light chains and kidney failure
12:35-12:55 Case-based lecture: How to treat bone disease Elena Zamagni (Bologna)
in multiple myeloma
12:55-13:00 Brief oral communication
Reductions in absolute iFLC and dFLC are associated with Efstathios Kastritis (Athens)
prolonged major organ deterioration progression-free survival in patients with newly diagnosed AL
amyloidosis receiving VCD with or without Daratumumab: results from ANDROMEDA
13:00- 13:30 Panel discussion
13:30-14:00 Lunch
14:00-15:00 KEYNOTE LECTURES:
The future of multiple myeloma
Chair: Kenneth C. Anderson (Boston)
14:00-14:05 Introduction Kenneth C. Anderson (Boston)
14:05 -14.25 There is no future without past Kenneth C. Anderson (Boston)
14.25 - 14:45 The future is now, science fiction thereafter Francesca Gay (Turin)
14:45-15:00 Discussion
15:00-15:05 Closing remarks
MEETING CLOSURE
6